The STEPwise (TM) randomised, controlled, 48-week trial: intensifying treatment with stepwise addition of prandial insulin aspart, based on largest prandial glucose increment or largest meal, to once daily basal insulin detemir in subjects with type 2 diabetes

Abstract

Abstract is not available.